Brief: Jw Cayman Therapeutics Has Been Included In Hong Kong Stock Connect List Under Shenzhen-Hong Kong Stock Connect
15/03/2021 14:16
March 15 (Reuters) - JW Cayman Therapeutics Co Ltd
2126.HK :
* CO HAS BEEN INCLUDED IN HONG KONG STOCK CONNECT LIST UNDER
SHENZHEN-HONG KONG STOCK CONNECT, WITH EFFECT ON MARCH 15
Source text for Eikon: ID:nHKS7H7Sp1
Further company coverage: 2126.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on JW (Cayman) Therapeutics Co
See all newsChina pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Brief: JW (Cayman) Therapeutics Appoints Tian Feng As CEO, Executive Director
Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment
Brief: JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million
Brief: JW (Cayman) Therapeutics Grants Juno Therapeutics Non-Exclusive License